Cargando…
Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
Parkinson's disease (PD) is the second most common neurodegenerative disorder and prevalence increases with age. Normal physiological changes that occur during the aging process reflect the pathological characteristics of Parkinson's disease. It is also recognized that age related changes...
Autores principales: | Grimmig, Beth, Daly, Lauren, Subbarayan, Meena, Hudson, Ched, Williamson, Robert, Nash, Kevin, Bickford, Paula C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828206/ https://www.ncbi.nlm.nih.gov/pubmed/29535814 http://dx.doi.org/10.18632/oncotarget.23737 |
Ejemplares similares
-
T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
por: Subbarayan, Meena S., et al.
Publicado: (2020) -
Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
por: Grimmig, Bethany, et al.
Publicado: (2016) -
Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
por: Winter, Aimee N., et al.
Publicado: (2020) -
Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease
por: Shahaduzzaman, Md, et al.
Publicado: (2015) -
On the Neuroprotective Role of Astaxanthin: New Perspectives?
por: Galasso, Christian, et al.
Publicado: (2018)